カテゴリー： QYResearch, 世界

中枢神経系疾患薬品の世界市場：規模・現状・予測

◆英語タイトル：Global Drugs for Central Nervous System Diseases Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18410
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：96
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、中枢神経系疾患薬品の世界市場について調査・分析し、中枢神経系疾患薬品の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ薬、抗不安薬、抗躁薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の中枢神経系疾患薬品市場動向
・主要企業別マーケットシェア
・中枢神経系疾患薬品の種類別市場規模2014-2019
（抗うつ薬、抗不安薬、抗躁薬、その他）
・中枢神経系疾患薬品の用途別市場規模2014-2019
（病院薬局、小売薬局、オンライン薬局）
・中枢神経系疾患薬品の北米市場：主要企業・種類別/用途別市場規模
・中枢神経系疾患薬品のヨーロッパ市場：主要企業・種類別/用途別市場規模
・中枢神経系疾患薬品の中国市場：主要企業・種類別/用途別市場規模
・中枢神経系疾患薬品の日本国内市場：主要企業・種類別/用途別市場規模
・中枢神経系疾患薬品の東南アジア市場：主要企業・種類別/用途別市場規模
・中枢神経系疾患薬品のインド市場：主要企業・種類別/用途別市場規模
・中枢神経系疾患薬品の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Alkermes、Astrazeneca、Biogen、Bristol Myers Squibb、Lilly、GSK、Merck、Sunovion Pharmaceuticals、Pfizer、Teva、Norvatis）
・中枢神経系疾患薬品の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Drugs for Central Nervous System Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drugs for Central Nervous System Diseases development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Alkermes
Astrazeneca
Biogen
Bristol Myers Squibb
Lilly
GSK
Merck
Sunovion Pharmaceuticals
Pfizer
Teva
Norvatis

Market segment by Type, the product can be split into
Antidepressants
Anxiolytics
Anti-manic
Other

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Drugs for Central Nervous System Diseases status, future forecast, growth opportunity, key market and key players.
To present the Drugs for Central Nervous System Diseases development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Drugs for Central Nervous System Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drugs for Central Nervous System Diseases Market Size Growth Rate by Type (2014-2025)
1.4.2 Antidepressants
1.4.3 Anxiolytics
1.4.4 Anti-manic
1.4.5 Other
1.5 Market by Application
1.5.1 Global Drugs for Central Nervous System Diseases Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Drugs for Central Nervous System Diseases Market Size
2.2 Drugs for Central Nervous System Diseases Growth Trends by Regions
2.2.1 Drugs for Central Nervous System Diseases Market Size by Regions (2019-2025)
2.2.2 Drugs for Central Nervous System Diseases Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Drugs for Central Nervous System Diseases Market Size by by Players
3.1.1 Global Drugs for Central Nervous System Diseases Revenue by by Players (2014-2019)
3.1.2 Global Drugs for Central Nervous System Diseases Revenue Market Share by by Players (2014-2019)
3.1.3 Global Drugs for Central Nervous System Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Drugs for Central Nervous System Diseases Key Players Head office and Area Served
3.3 Key Players Drugs for Central Nervous System Diseases Product/Solution/Service
3.4 Date of Enter into Drugs for Central Nervous System Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Drugs for Central Nervous System Diseases Market Size by Type (2014-2019)
4.2 Global Drugs for Central Nervous System Diseases Market Size by Application (2014-2019)

5 North America
5.1 North America Drugs for Central Nervous System Diseases Market Size (2014-2019)
5.2 Drugs for Central Nervous System Diseases Key Players in North America
5.3 North America Drugs for Central Nervous System Diseases Market Size by Type
5.4 North America Drugs for Central Nervous System Diseases Market Size by Application

6 Europe
6.1 Europe Drugs for Central Nervous System Diseases Market Size (2014-2019)
6.2 Drugs for Central Nervous System Diseases Key Players in Europe
6.3 Europe Drugs for Central Nervous System Diseases Market Size by Type
6.4 Europe Drugs for Central Nervous System Diseases Market Size by Application

7 China
7.1 China Drugs for Central Nervous System Diseases Market Size (2014-2019)
7.2 Drugs for Central Nervous System Diseases Key Players in China
7.3 China Drugs for Central Nervous System Diseases Market Size by Type
7.4 China Drugs for Central Nervous System Diseases Market Size by Application

8 Japan
8.1 Japan Drugs for Central Nervous System Diseases Market Size (2014-2019)
8.2 Drugs for Central Nervous System Diseases Key Players in Japan
8.3 Japan Drugs for Central Nervous System Diseases Market Size by Type
8.4 Japan Drugs for Central Nervous System Diseases Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Drugs for Central Nervous System Diseases Market Size (2014-2019)
9.2 Drugs for Central Nervous System Diseases Key Players in Southeast Asia
9.3 Southeast Asia Drugs for Central Nervous System Diseases Market Size by Type
9.4 Southeast Asia Drugs for Central Nervous System Diseases Market Size by Application

10 India
10.1 India Drugs for Central Nervous System Diseases Market Size (2014-2019)
10.2 Drugs for Central Nervous System Diseases Key Players in India
10.3 India Drugs for Central Nervous System Diseases Market Size by Type
10.4 India Drugs for Central Nervous System Diseases Market Size by Application

11 Central & South America
11.1 Central & South America Drugs for Central Nervous System Diseases Market Size (2014-2019)
11.2 Drugs for Central Nervous System Diseases Key Players in Central & South America
11.3 Central & South America Drugs for Central Nervous System Diseases Market Size by Type
11.4 Central & South America Drugs for Central Nervous System Diseases Market Size by Application

12 International Players Profiles
12.1 Alkermes
12.1.1 Alkermes Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drugs for Central Nervous System Diseases Introduction
12.1.4 Alkermes Revenue in Drugs for Central Nervous System Diseases Business (2014-2019))
12.1.5 Alkermes Recent Development
12.2 Astrazeneca
12.2.1 Astrazeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drugs for Central Nervous System Diseases Introduction
12.2.4 Astrazeneca Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.2.5 Astrazeneca Recent Development
12.3 Biogen
12.3.1 Biogen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drugs for Central Nervous System Diseases Introduction
12.3.4 Biogen Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.3.5 Biogen Recent Development
12.4 Bristol Myers Squibb
12.4.1 Bristol Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drugs for Central Nervous System Diseases Introduction
12.4.4 Bristol Myers Squibb Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.4.5 Bristol Myers Squibb Recent Development
12.5 Lilly
12.5.1 Lilly Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drugs for Central Nervous System Diseases Introduction
12.5.4 Lilly Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.5.5 Lilly Recent Development
12.6 GSK
12.6.1 GSK Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drugs for Central Nervous System Diseases Introduction
12.6.4 GSK Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.6.5 GSK Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drugs for Central Nervous System Diseases Introduction
12.7.4 Merck Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Sunovion Pharmaceuticals
12.8.1 Sunovion Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drugs for Central Nervous System Diseases Introduction
12.8.4 Sunovion Pharmaceuticals Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.8.5 Sunovion Pharmaceuticals Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drugs for Central Nervous System Diseases Introduction
12.9.4 Pfizer Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Teva
12.10.1 Teva Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drugs for Central Nervous System Diseases Introduction
12.10.4 Teva Revenue in Drugs for Central Nervous System Diseases Business (2014-2019)
12.10.5 Teva Recent Development
12.11 Norvatis

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Drugs for Central Nervous System Diseases Key Market Segments
Table Key Players Drugs for Central Nervous System Diseases Covered
Table Global Drugs for Central Nervous System Diseases Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Antidepressants Figures
Table Key Players of Antidepressants
Figuer Anxiolytics Figures
Table Key Players of Anxiolytics
Figuer Anti-manic Figures
Table Key Players of Anti-manic
Figuer Other Figures
Table Key Players of Other
Table Global Drugs for Central Nervous System Diseases Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Drugs for Central Nervous System Diseases Market Share by Application in 2018 & 2025
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Drugs for Central Nervous System Diseases Report Years Considered
Figure Global Drugs for Central Nervous System Diseases Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Drugs for Central Nervous System Diseases Market Size by Regions 2019-2025 (Million US$)
Table Global Drugs for Central Nervous System Diseases Market Size by Regions 2019-2025 (Million US$)
Table Global Drugs for Central Nervous System Diseases Market Share by Regions 2014-2019
Figure Global Drugs for Central Nervous System Diseases Market Share by Regions 2014-2019
Figure Global Drugs for Central Nervous System Diseases Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Drugs for Central Nervous System Diseases Revenue by by Players (2014-2019) (Million US$)
Table Global Drugs for Central Nervous System Diseases Market Share by by Players (2014-2019)
Figure Global Drugs for Central Nervous System Diseases Market Share by by Players in 2018
Table Global Drugs for Central Nervous System Diseases by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Drugs for Central Nervous System Diseases Product/Solution/Service
Table Date of Enter into Drugs for Central Nervous System Diseases Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Drugs for Central Nervous System Diseases Market Size by Type (2014-2019) (Million US$)
Table Global Drugs for Central Nervous System Diseases Market Size Share by Type (2014-2019)
Figure Global Drugs for Central Nervous System Diseases Market Size Market Share by Type (2014-2019)
Table Global Drugs for Central Nervous System Diseases Market Size by Application (2014-2019) (Million US$)
Table Global Drugs for Central Nervous System Diseases Market Size Share by Application (2014-2019)
Figure Global Drugs for Central Nervous System Diseases Market Size Market Share by Application (2014-2019)
Figure Global Drugs for Central Nervous System Diseases Revenue Market Share by Application in 2018
Figure North America Drugs for Central Nervous System Diseases Market Size 2014-2019 (Million US$)
Table North America Key Players Drugs for Central Nervous System Diseases Revenue (2018-2019) (Million US$)
Table North America Key Players Drugs for Central Nervous System Diseases Market Share (2018-2019)
Table North America Drugs for Central Nervous System Diseases Market Size by Type 2014-2019 (Million US$)
Table North America Drugs for Central Nervous System Diseases Market Share by Type 2014-2019
Table North America Drugs for Central Nervous System Diseases Market Size by Application 2014-2019 (Million US$)
Table North America Drugs for Central Nervous System Diseases Market Share by Application 2014-2019
Figure Europe Drugs for Central Nervous System Diseases Market Size 2014-2019 (Million US$)
Table Europe Key Players Drugs for Central Nervous System Diseases Revenue (2018-2019) (Million US$)
Table Europe Key Players Drugs for Central Nervous System Diseases Market Share (2018-2019)
Table Europe Drugs for Central Nervous System Diseases Market Size by Type 2014-2019 (Million US$)
Table Europe Drugs for Central Nervous System Diseases Market Share by Type 2014-2019
Table Europe Drugs for Central Nervous System Diseases Market Size by Application 2014-2019 (Million US$)
Table Europe Drugs for Central Nervous System Diseases Market Share by Application 2014-2019
Figure China Drugs for Central Nervous System Diseases Market Size 2014-2019 (Million US$)
Table China Key Players Drugs for Central Nervous System Diseases Revenue (2018-2019) (Million US$)
Table China Key Players Drugs for Central Nervous System Diseases Market Share (2018-2019)
Table China Drugs for Central Nervous System Diseases Market Size by Type 2014-2019 (Million US$)
Table China Drugs for Central Nervous System Diseases Market Share by Type 2014-2019
Table China Drugs for Central Nervous System Diseases Market Size by Application 2014-2019 (Million US$)
Table China Drugs for Central Nervous System Diseases Market Share by Application 2014-2019
Figure Japan Drugs for Central Nervous System Diseases Market Size 2014-2019 (Million US$)
Table Japan Key Players Drugs for Central Nervous System Diseases Revenue (2018-2019) (Million US$)
Table Japan Key Players Drugs for Central Nervous System Diseases Market Share (2018-2019)
Table Japan Drugs for Central Nervous System Diseases Market Size by Type 2014-2019 (Million US$)
Table Japan Drugs for Central Nervous System Diseases Market Share by Type 2014-2019
Table Japan Drugs for Central Nervous System Diseases Market Size by Application 2014-2019 (Million US$)
Table Japan Drugs for Central Nervous System Diseases Market Share by Application 2014-2019
Figure Southeast Asia Drugs for Central Nervous System Diseases Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Drugs for Central Nervous System Diseases Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Drugs for Central Nervous System Diseases Market Share (2018-2019)
Table Southeast Asia Drugs for Central Nervous System Diseases Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Drugs for Central Nervous System Diseases Market Share by Type 2014-2019
Table Southeast Asia Drugs for Central Nervous System Diseases Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Drugs for Central Nervous System Diseases Market Share by Application 2014-2019
Figure India Drugs for Central Nervous System Diseases Market Size 2014-2019 (Million US$)
Table India Key Players Drugs for Central Nervous System Diseases Revenue (2018-2019) (Million US$)
Table India Key Players Drugs for Central Nervous System Diseases Market Share (2018-2019)
Table India Drugs for Central Nervous System Diseases Market Size by Type 2014-2019 (Million US$)
Table India Drugs for Central Nervous System Diseases Market Share by Type 2014-2019
Table India Drugs for Central Nervous System Diseases Market Size by Application 2014-2019 (Million US$)
Table India Drugs for Central Nervous System Diseases Market Share by Application 2014-2019
Figure Central & South America Drugs for Central Nervous System Diseases Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Drugs for Central Nervous System Diseases Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Drugs for Central Nervous System Diseases Market Share (2018-2019)
Table Central & South America Drugs for Central Nervous System Diseases Market Size by Type 2014-2019 (Million US$)
Table Central & South America Drugs for Central Nervous System Diseases Market Share by Type 2014-2019
Table Central & South America Drugs for Central Nervous System Diseases Market Size by Application 2014-2019 (Million US$)
Table Central & South America Drugs for Central Nervous System Diseases Market Share by Application 2014-2019
Table Alkermes Company Details
Table Alkermes Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Alkermes Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Alkermes Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Astrazeneca Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Astrazeneca Recent Development
Table Biogen Company Details
Table Biogen Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Biogen Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Biogen Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Lilly Company Details
Table Lilly Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Lilly Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Lilly Recent Development
Table GSK Company Details
Table GSK Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure GSK Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table GSK Recent Development
Table Merck Company Details
Table Merck Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Merck Recent Development
Table Sunovion Pharmaceuticals Company Details
Table Sunovion Pharmaceuticals Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Sunovion Pharmaceuticals Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Sunovion Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Pfizer Recent Development
Table Teva Company Details
Table Teva Revenue in Drugs for Central Nervous System Diseases Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Drugs for Central Nervous System Diseases Business (2014-2019)
Table Teva Recent Development
Table Norvatis Company Details
Table Global Drugs for Central Nervous System Diseases Market Size by Regions (Million US$) 2019-2025
Figure Global Drugs for Central Nervous System Diseases Market Size Share by Regions (2019-2025)
Figure Global Drugs for Central Nervous System Diseases Market Size Share by Regions in 2025
Figure North America Drugs for Central Nervous System Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Europe Drugs for Central Nervous System Diseases Market Size Forecast (2019-2025)(Million USD)
Figure China Drugs for Central Nervous System Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Japan Drugs for Central Nervous System Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Drugs for Central Nervous System Diseases Market Size Forecast (2019-2025)(Million USD)
Figure India Drugs for Central Nervous System Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Drugs for Central Nervous System Diseases Market Size Forecast (2019-2025)(Million USD)
Table Global Drugs for Central Nervous System Diseases Market Size by Product (2019-2025) (Million US$)
Figure Global Drugs for Central Nervous System Diseases Market Size by Product (2019-2025)
Figure Global Drugs for Central Nervous System Diseases Market Size by Product in 2025
Table Global Drugs for Central Nervous System Diseases Market Size by Application (2019-2025) (Million US$)
Figure Global Drugs for Central Nervous System Diseases Market Size by Application (2019-2025)
Figure Global Drugs for Central Nervous System Diseases Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Alkermes、Astrazeneca、Biogen、Bristol Myers Squibb、Lilly、GSK、Merck、Sunovion Pharmaceuticals、Pfizer、Teva、Norvatis

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 中枢神経系疾患薬品の世界市場：規模・現状・予測(Global Drugs for Central Nervous System Diseases Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp